Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Caterpillar fungus believed to cure ailments
Scientists discover fungus has anti-inflammatory properties

A new study, published in the journal RNA, has shed light on the “golden worm” or “Tibetan mushroom” thought by locals in Tibet to cure everything from cancer to asthma to erectile dysfunction.

For a Tibetan mushroom to form, a fungus must attach itself to a moth larva burrowed in the soil. It will then slowly consume the host from within, taking over its brain and making the young caterpillar move to position which the fungus can grow and spore again.

The parasite is called cordyceps and produces the chemical cordycepin which scientists now believe has anti-inflammatory properties.

Study co-author Cornelia H. de Moor, of the University of Nottingham, explained: "Inflammation is normally a beneficial response to a wound or infection, but in diseases like asthma it happens too fast and to too high of an extent. When cordycepin is present, it inhibits that response strongly."

The chemical does this in a way not previously seen: at the mRNA stage, where it inhibits polyadenylation. This means it stops swelling at the genetic cellular level - a novel anti-inflammatory approach that could lead to new drugs for cancer, asthma, diabetes, rheumatoid arthritis, and cardiovascular-disease patients who don't respond well to current medications.

However, these new drugs may be a long way off. The science of parasitic fungi is still in its early stages, and no medicine currently available utilises cordycepin as an anti-inflammatory. The only way a patient could gain its benefits would be by consuming wild-harvested mushrooms.

"I can't recommend taking wild-harvested medications," warned de Moor. "Each sample could have a completely different dose, and there are mushrooms where a single bite will kill you."

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Government releases latest bluetongue statistics

APHA has confirmed the number of bluetongue cases that have been logged in the UK since 1 July 2026.

The total number of BTV-3 cases, as of 6 August, is 187. This includes 183 cases in England and four cases in Wales.

There have been no recorded cases in Scotland and Northern Ireland.

The location of premises in Great Britain where at least one animal has tested positive by PCR for BTV-3, BTV-8 or BTV-12 is available on the bluetongue case map. All livestock keepers in Great Britain are urged to familiarise themselves with nation-specific bluetongue control policies.

Bluetongue virus is a notifiable disease. It is a legal requirement that any suspicions, even if livestock has been vaccinated, are reported immediately.